S. Freedland
Genetics · 2005–2017
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 9 citations into it
Whom S. Freedland trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from S. Freedland's perspective
Ordered by how strongly the researchers S. Freedland trusts endorse each paper. Same corpus, a different order for every researcher.
- Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (New England Journal of Medicine)
- Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. (New England Journal of Medicine)
- Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis
- Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. (Journal of the American Medical Association (JAMA))
- Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. (Journal of Clinical Oncology)
- European Organization for Research and Treatment of Cancer
- Radical prostatectomy versus watchful waiting in early prostate cancer. (Journal of Urology)
- The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer (Nature)
- Integrative genomic profiling of human prostate cancer (Cancer Cell)
- Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer (Nature)
Their papers
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options (2017) — 876 citations
- The molecular taxonomy of primary prostate cancer (2015) — 2,751 citations
- Autonomic Nerve Development Contributes to Prostate Cancer Progression (2013) — 1,107 citations
- Early Detection of Prostate Cancer: AUA Guideline (2013) — 1,178 citations
- Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. (2008) — 667 citations
- Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. (2005) — 1,402 citations